Pascal S.
- Country
- France
- Department
- Internal medicine
Research Overview
- Comparative Efficacy and Safety of Adalimumab Versus Mycophenolate Mofetil in Steroid-Dependent Non-Infectious Uveitis
- Evaluation of Remission Maintenance with Extended Prednisone Administration in ANCA-Associated Vasculitis Using Rituximab Therapy
- Evaluation of Baricitinib Efficacy in Refractory Non-Infectious Non-Anterior Uveitis: A Clinical Trial
Data & Insights
Has run more than one trial at 26 of 64 partner sites.
Specializations
Inflammatory Eye Disorders
Specializes in treating complex non-infectious uveitis conditions, with particular focus on innovative therapeutic approaches using biological agents and targeted therapies.
- Non-anterior uveitis management
- Intermediate and posterior uveitis
- Therapeutic drug monitoring
Investigates novel treatment strategies including JAK inhibitors and adalimumab for refractory cases.
Autoimmune Conditions
Focuses on treating systemic vasculitis and related autoimmune disorders, with expertise in developing maintenance therapy protocols.
- ANCA-associated vasculitis
- Granulomatosis with polyangiitis
- Microscopic polyangiitis
Explores long-term remission strategies using rituximab and corticosteroid management.
Inflammatory Diseases
Specializes in the treatment of sarcoidosis with particular emphasis on innovative therapeutic approaches and treatment optimization.
- Pulmonary sarcoidosis
- TNF-alpha antagonist therapy
- Corticosteroid optimization
Investigates combination therapies including hydroxychloroquine with low-dose corticosteroids.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.